Cargando…

Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China

INTRODUCTION: Current guidelines recommend amphotericin B as the preferred drug for induction therapy; however, amphotericin B is not available in certain settings. Induction therapy with amphotericin B deoxycholate or voriconazole has been shown to be an effective treatment for talaromycosis. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yihong, Qin, Yuanyuan, Lu, Yanqiu, Yuan, Jing, Nie, Jingmin, Liu, Min, Tian, Qun, Lan, Ke, Zhou, Guoqiang, Qin, Yingmei, He, Kaiyin, Yu, Jianhua, Jiang, Zhongsheng, Liu, Jun, Liu, Shuiqing, Harypursat, Vijay, Chen, Yaokai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334509/ https://www.ncbi.nlm.nih.gov/pubmed/35689792 http://dx.doi.org/10.1007/s40121-022-00658-0

Ejemplares similares

Severe anemia, severe leukopenia, and severe thrombocytopenia of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated talaromycosis: a subgroup analysis of a prospective multicenter cohort study
por: Zhou, Yihong, et al.
Publicado: (2023)

Multicentre derivation and validation of a prognostic scoring system for mortality assessment in HIV‐infected patients with talaromycosis
por: Qin, Yuanyuan, et al.
Publicado: (2020)

Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China
por: Zhao, Ting, et al.
Publicado: (2022)

Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis
por: Jiang, Zhiwen, et al.
Publicado: (2022)

Cost-Effectiveness of Amphotericin B Deoxycholate Versus Itraconazole for Induction Therapy of Talaromycosis in Human Immunodeficiency Virus–Infected Adults in Vietnam
por: Buchanan, James, et al.
Publicado: (2021)

No Statistically Apparent Difference in Antifungal Effectiveness Observed Among Trimethoprim/Sulfamethoxazole Plus Clindamycin or Caspofungin, and Trimethoprim/Sulfamethoxazole Monotherapy in HIV-Infected Patients with Moderate to Severe Pneumocystis Pneumonia: Results of an Observational Multicenter Cohort Study
por: Huang, Yinqiu, et al.
Publicado: (2022)

Independent Risk Factors for Deaths due to AIDS in Chongqing, China: Does Age Matter?
por: Zhou, Yihong, et al.
Publicado: (2021)

An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease
por: Zaongo, Silvere D., et al.
Publicado: (2023)

JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review
por: Harypursat, Vijay, et al.
Publicado: (2020)

Acute hepatic injury with amphotericin B deoxycholate in an immunocompetent patient
por: Wagner, Jamie L., et al.
Publicado: (2016)

Effect of deoxycholate, amphotericin B and fongizone on transmissible gastroenteritis coronavirus
por: Nguyen, T.D., et al.
Publicado: (1987)

In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates
por: Montagna, Maria Teresa, et al.
Publicado: (2014)

Changes of human immunodeficiency virus (HIV) burden globally and in China over three decades: a secondary analysis of global HIV statistics
por: Lu, Yanqiu, et al.
Publicado: (2022)

Timing of antiretroviral therapy for HIV-infected patients with moderate to severe Pneumocystis pneumonia: study protocol for a multi-centre prospective randomised controlled trial
por: Qin, Yuanyuan, et al.
Publicado: (2020)

Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate
por: Chandrasekar, PH
Publicado: (2008)

Efficacy of voriconazole and amphotericin B in corneal preservative media
por: Das, Sujata, et al.
Publicado: (2022)

Continuous versus Conventional Infusion of Amphotericin B Deoxycholate: A Meta-Analysis
por: Falagas, Matthew E., et al.
Publicado: (2013)

Successful Treatment of Protothecal Tenosynovitis in an Immunocompetent Patient using Amphotericin B Deoxycholate
por: Kim, Ji-Eun, et al.
Publicado: (2017)

Population Pharmacodynamics of Amphotericin B Deoxycholate for Disseminated Infection Caused by Talaromyces marneffei
por: Le, Thuy, et al.
Publicado: (2019)

Cyanotic Raynaud's phenomenon induced by amphotericin B deoxycholate: A case report
por: Hatem, Nayla A., et al.
Publicado: (2023)

Amphotericin-B-liposomal/voriconazole: Renal impairment: case report
Publicado: (2021)

A Dual Role of Heme Oxygenase-1 in Tuberculosis
por: Yang, Sen, et al.
Publicado: (2022)

Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp.
por: Rodrigues, Célia F., et al.
Publicado: (2017)

Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study
por: Hasnain, Md Golam, et al.
Publicado: (2018)

Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B
por: Efe İris, Nur, et al.
Publicado: (2016)

Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
por: Bicanic, Tihana, et al.
Publicado: (2015)

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis
por: Benjamin, Daniel K., et al.
Publicado: (2018)

P-Selectin Glycoprotein Ligand 1: A Potential HIV-1 Therapeutic Target
por: Zaongo, Silvere D., et al.
Publicado: (2021)

Amphotericin B May Decrease the Serum Level of Voriconazole: A Case Report and Brief Review of Literature
por: Hu, Zhen, et al.
Publicado: (2022)

The delayed clearance of Talaromyces marneffei in blood culture may be associated with higher MIC of voriconazole after antifungal therapy among AIDS patients with talaromycosis
por: Guo, Pengle, et al.
Publicado: (2023)

Refractory Scedosporium apiospermum Keratitis Successfully Treated with Combination of Amphotericin B and Voriconazole
por: Fadzillah, Mohd-Tahir, et al.
Publicado: (2013)

Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report
por: Akers, Kevin S, et al.
Publicado: (2015)

Filamentous fungal endophthalmitis: results of combination therapy with intravitreal amphotericin B and voriconazole
por: Mithal, Kopal, et al.
Publicado: (2015)

Effective Voriconazole in an Immunocompetent Patient With Amphotericin B Resistant Systemic Cryptococcal Granulomatosis
por: Serraj, Khalid, et al.
Publicado: (2020)

Amphotericin-B-liposomal/isavuconazole/voriconazole: Lack of efficacy: 6 case report
Publicado: (2022)

In vitro antifungal susceptibilities of Candida species to liposomal amphotericin B, determined using CLSI broth microdilution, and amphotericin B deoxycholate, measured using the Etest
por: Lovero, Grazia, et al.
Publicado: (2017)

Intravenous Itraconazole vs. Amphotericin B Deoxycholate for Empirical Antifungal Therapy in Patients with Persistent Neutropenic Fever
por: Park, Sun Hee, et al.
Publicado: (2006)

Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis
por: Stott, Katharine E., et al.
Publicado: (2018)

Antileishmanial Activity and Synergistic Effects of Amphotericin B Deoxycholate with Allicin and Andrographolide against Leishmania martiniquensis In Vitro
por: Intakhan, Nuchpicha, et al.
Publicado: (2020)

Disseminated talaromycosis in an HIV-infected patient
por: Chang, Chee Yik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g2855e5enit1ob5m1ckghk3hev